Everolimus in pituitary tumor: a review of preclinical and clinical evidence.

Front Endocrinol (Lausanne) · 2024 · PMC11682973 · PMID 39736867

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Given the effect of PTs genotypes on EVE efficacy, exploring personalized EVE treatments for different genotypes could be highly significant. 3.3.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.